Medivation Inc. buy melinda
Start price
03.03.13
/
50%
€17.65
Target price
03.09.13
€19.00
Performance (%)
19.95%
End price
03.09.13
€21.17
Summary
This prediction ended on 03.09.13 with a price of €21.17. The prediction had a final performance of 19.95%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Medivation Inc. | - | - | - | - |
iShares Core DAX® | 0.238% | -2.265% | 13.679% | 14.917% |
iShares Nasdaq 100 | -0.304% | 5.808% | 34.538% | 52.796% |
iShares Nikkei 225® | 2.271% | 1.577% | 9.436% | 5.432% |
iShares S&P 500 | -0.296% | 4.447% | 28.577% | 47.257% |
Comments by melinda for this prediction
In the thread Medivation Inc. diskutieren
schwere Krankheiten Behandlung
Medivation Inc. biopharmazeutische in Zusammenarbeit mit Pfizer über Krankheiten (alzh / Prostata) bekannt
(Laufzeit überschritten)